Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Stefanie C McFarlane"'
Autor:
Shaji Sebastian, Laurent Peyrin-Biroulet, Silvio Danese, Séverine Vermeire, Simon Travis, Jean-Frederic Colombel, Brian G Feagan, Vipul Jairath, Guangyong Zou, Geert R D’Haens, William J Sandborn, Gordon W Moran, Christopher Ma, Peter Bossuyt, Daniel Green, Mark S Silverberg, Maria Kłopocka, Marek Horynski, Stefanie C McFarlane, Zhongya Wang, Shashi Adsul, Marcelo Freire, Gabriela Radulescu, Julie Sigler, Jurij Hanžel, Rocio Sedano, Naveen Arya, Melanie Beaton, William Harlan, Rima Petroniene, Lukasz Wolanski
Publikováno v:
BMJ Open Gastroenterology, Vol 11, Iss 1 (2024)
Introduction Symptoms, endoscopy and histology have been proposed as therapeutic targets in ulcerative colitis (UC). Observational studies suggest that the achievement of histologic remission may be associated with a lower risk of complications, comp
Externí odkaz:
https://doaj.org/article/90b48a3e247b434da3279f2d6dcef059
Autor:
Brian G Feagan, Vipul Jairath, Reetesh K Pai, Rish K Pai, Amitabh Srivastava, Christopher Ma, Christophe Rosty, David F Schaeffer, Roger M Feakins, Gregory Y Lauwers, Jonathan Krell, Richard Kirsch, Leonardo Guizzetti, John K MacDonald, Won-Tak Choi, Stefanie C McFarlane, Joanna C. Walsh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Immune checkpoint inhibitor-associated colitis (ICIC) affects approximately 15% of cancer patients treated with immunotherapy. Although histological evaluation is potentially valuable for both the diagnosis of ICIC and evaluation of disease activity,
Externí odkaz:
https://doaj.org/article/68c745c8e80e44898d2db6645e7a63b2
Autor:
Rish K. Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A. Adeyi, Quentin M. Anstee, Bashar A. Aqel, Cynthia Behling, Elizabeth J. Carey, Andrew D. Clouston, Kathleen Corey, Brian G. Feagan, David E. Kleiner, Christopher Ma, Stefanie C. McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A. Valasek, Zobair M. Younossi, Stephen A. Harrison, Rohit Loomba
Publikováno v:
Hepatology. 76:1150-1163
The NASH Clinical Research Network histologic scoring system, the gold-standard NASH histology assessment for clinical trials, has demonstrated intrarater and interrater variability. An expert panel in a previous systematic Research and Development/U
Autor:
Christopher Ma, Jurij Hanzel, Remo Panaccione, William J. Sandborn, Geert R. D’Haens, Vineet Ahuja, Raja Atreya, Charles N. Bernstein, Peter Bossuyt, Brian Bressler, Robert V. Bryant, Benjamin Cohen, Jean-Frederic Colombel, Silvio Danese, Axel Dignass, Marla C. Dubinsky, Phillip R. Fleshner, Richard B. Gearry, Stephen B. Hanauer, Ailsa Hart, Paulo Gustavo Kotze, Torsten Kucharzik, Peter L. Lakatos, Rupert W. Leong, Fernando Magro, Julian Panés, Laurent Peyrin-Biroulet, Zhihua Ran, Miguel Regueiro, Siddharth Singh, Antonino Spinelli, A. Hillary Steinhart, Simon P. Travis, C. Janneke van der Woude, Bruce Yacyshyn, Takayuki Yamamoto, Matthieu Allez, Willem A. Bemelman, Amy L. Lightner, Edouard Louis, David T. Rubin, Ellen J. Scherl, Corey A. Siegel, Mark S. Silverberg, Severine Vermeire, Claire E. Parker, Stefanie C. McFarlane, Leonardo Guizzetti, Michelle I. Smith, Niels Vande Casteele, Brian G. Feagan, Vipul Jairath
Publikováno v:
Gastroenterology, 163(4), 950-964. W.B. Saunders
Gastroenterology, 163(4), 950-964. W.B. Saunders Ltd
Gastroenterology, 163(4), 950-964. W.B. Saunders Ltd
BACKGROUND & AIMS: End points to determine the efficacy and safety of medical therapies for Crohn's disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, harmonizing end points in a core outcome s
Autor:
Christopher Ma, Rish K Pai, David F Schaeffer, Jonathan Krell, Leonardo Guizzetti, Stefanie C McFarlane, John K MacDonald, Won-Tak Choi, Roger M Feakins, Richard Kirsch, Gregory Y Lauwers, Reetesh K Pai, Christophe Rosty, Amitabh Srivastava, Joanna C. Walsh, Brian G Feagan, Vipul Jairath
Publikováno v:
Journal for immunotherapy of cancer, vol 10, iss 3
Immune checkpoint inhibitor-associated colitis (ICIC) affects approximately 15% of cancer patients treated with immunotherapy. Although histological evaluation is potentially valuable for both the diagnosis of ICIC and evaluation of disease activity,
Autor:
Rish K. Pai, Albert J. Bredenoord, Evan S. Dellon, Willemijn E. de Rooij, Ikuo Hirano, Brian G. Feagan, Guangyong Zou, Leonardo Guizzetti, Margaret H. Collins, David F. Schaeffer, Christopher Ma, Lisa M. Shackelton, Vipul Jairath, Stefanie C. McFarlane
Publikováno v:
American journal of gastroenterology, 117(2), 264-271. Springer Nature
Introduction The optimal instrument for assessing histologic disease activity in patients with eosinophilic esophagitis (EoE) is unclear. We assessed the responsiveness of the EoE Histologic Scoring System (EoE-HSS) when compared with that of the pea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5668e87bf3240f7c770e5ffd94be3e68
https://pure.amc.nl/en/publications/responsiveness-of-a-histologic-scoring-system-compared-with-peak-eosinophil-count-in-eosinophilic-esophagitis(32a65e4f-a883-459f-84e7-4949b1ae5181).html
https://pure.amc.nl/en/publications/responsiveness-of-a-histologic-scoring-system-compared-with-peak-eosinophil-count-in-eosinophilic-esophagitis(32a65e4f-a883-459f-84e7-4949b1ae5181).html
Autor:
Jurij Hanžel, Rocio Sedano, Jenny Jeyarajah, Guangyong Zou, Stefanie C McFarlane, Christopher Ma, Vipul Jairath
Publikováno v:
Inflammatory bowel diseases. 28(9)
Lay Summary We conducted a systematic review and metaregression of pivotal Crohn’s disease trials to evaluate the rates of change in Crohn’s Disease Activity Index scores in patients receiving biologic treatments. The speed of clinical improvemen
Autor:
Pavine Lefèvre, Leonardo Guizzetti, Trevor D. McKee, Guangyong Zou, Tanja van Viegen, Stefanie C. McFarlane, Lisa Shackelton, Brian G. Feagan, Vipul Jairath, Rish K. Pai, Niels Vande Casteele
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 30(7)
The T-lymphocyte-mediated inflammation in Crohn's disease can be assessed by quantifying CD3-positive T-lymphocyte counts in colonic sections. We developed and validated a process to reliably quantify immunohistochemical marker-positive cells in a hi